@AAAV_IMG_ Mejor el artículo: https://t.co/zoUyDYny0Y 🦠😷✌🏼
RT @CVR_TomaszGuzik: New #COVID19 randomised clinical study shows triple combination therapy of interferon beta-1b, ribavirin and lopinavir…
RT @WesElyMD: New #COVID19 Trials- Tx w combo-anti-HIV drugs no-go in NEJM https://t.co/Vny89JejJT BUT open label of same Lopin-Ritonavir +…
RT @gorka_orive: Un ensayo clínico reciente demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tra…
RT @gorka_orive: Un ensayo clínico reciente demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tra…
New #COVID19 randomised clinical study shows triple combination therapy of interferon beta-1b, ribavirin and lopinavir-ritonavir may be beneficial in mild-moderate COVID-19 patients but further research required https://t.co/1JUan1pRUR #SARSCoV2 #Lancet #C
Tentative evidence that ribavirin helps. Phase 2, not blinded, n=86. https://t.co/xzzftN5IHl https://t.co/0zE7P6MBlg
RT @rnovoa: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin to ease infecction of COVID19 https://t.co/3XHiUi…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin to ease infecction of COVID19 https://t.co/3XHiUi9vTL
New #COVID19 Trials- Tx w combo-anti-HIV drugs no-go in NEJM https://t.co/Vny89JejJT BUT open label of same Lopin-Ritonavir + Ribavirin & Interferon-B1b Lancet 6 sites (N=127) may shorten viral shedding & Hosp LOS. https://t.co/bHbnwjBGAZ. Trial de
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
#COVIDー19 Científicos de Univ de #HongKong evaluó la eficacia y seguridad de tres medicam antivirales: Interferón beta-1b Lopinavir-ritonavir Ribavirina Que al usarlos de manera combinada ayudaron a curar a las personas infectadas @msaludpy @TheLancet ht
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
@ani_digital @ANI Can anyone please start the trial in India for "Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin" and see its effectiveness, Seems to have worked well in phase2 trials in HongKong. https://t.co/2HHB9Gzv1p
@abpanandatv @IamSumanDe Look at this study published in The Lancet, a world-class journal, three drugs are in the queue of dawn, the hope of light for COVID-19. Interferon beta-1b, lopinavir-ritonavir, and ribavirin. https://t.co/DKNyvai3yx Anupam, Asst
RT @gorka_orive: Un ensayo clínico reciente demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tra…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @ALEX_MISCHIE: 🔴lopinavir/ritonavir + ribavirin + interferon beta-1b BETTER than lopinavir/ritonavir! https://t.co/JwmJvMrZzT @Shelle…
RT @gorka_orive: Un ensayo clínico reciente demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tra…
Un ensayo clínico reciente demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tratamiento de pacientes hospitalizados con #COVID19 resulta eficaz en reducir síntomas, diseminación viral y tiempo de hospitalización.
RT @MDMEDICINE1: A triple therapy that includes interferon β-1b shortened the duration of viral shedding in patients with novel #coronaviru…
A triple therapy that includes interferon β-1b shortened the duration of viral shedding in patients with novel #coronavirus disease (#Covid_19 ), according to a phase 2 randomized trial in the Lancet. https://t.co/no0mJZr6H9
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
Article libre accès https://t.co/9fM7qA3SKi #Covid_19 #lopinavir- #ritonavir + #ribavirine + #interféron bêta-1b versus #lopinavir- #ritonavir
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @tipssovetorax: #COVID19 Triple combinación: Interferon beta-1b, lopinavir/ritonavir, rivabirina. Ensayo clínico fase 2. @SOVETORAX htt…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @nathanpsmad: 🔥Interesting #RCT for #COVID19 #SARS_CoV_2 Interferon beta-1b, lopinavir–ritonavir, ribavirin in MILD patients (0 death,…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
RT @GaetanBurgio: This is an interesting study in @TheLancet on a phase 2 multi center randomized, open label clinical trial of interferon…
RT @gustavosm1: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospi…
lopinavir+ritonavir interferon beta 1b ribavirin what worked for chinese https://t.co/Y71MUenTeV
Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir–ritonavir, and ribavirin for treating patients with COVID-19...https://t.c
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/do8Iy1qYct
O artigo: https://t.co/ETkIqvXftM
Se evaluo la eficacia y la seguridad de la combinacion del Interferon beta 1b y lopinavir-ritonavir y la ribavirina para el tratamiento de pacientes de COVID19 https://t.co/z6cLHINZIr
RT @DougChinMD: More encouraging news in war on #COVID19 and #SARSCoV2 . Promising clinical trial of triple antiviral therapy (#lopinavir,…
the triple combination of antiviral therapy with interferon beta-1b, lopinavir–ritonavir shows excellent outcomes and faster recovery triple therapie composée de trois antiviraux dont l'interferon démontré d'excellents résultats source lancet https://t.c
More encouraging news in war on #COVID19 and #SARSCoV2 . Promising clinical trial of triple antiviral therapy (#lopinavir, #ritonavir, & #ribavirin) with #IFNgamma. Key may be early antiviral therapy prior to maladaptive immune response. https://t.
新型コロナを対象とした香港の臨床試験。カレトラ(HIV薬)単独よりも +インタフェロンb1b、リバビリンの3者併用が効いたという結果。全て既承認薬で効きそうなら何でも試そうといった感もあるが、ある意味既存薬はこうした実薬同士の比較試験を繰返すのが倫理的と思う。 https://t.co/59aO4QR1dd
RT @DavidBarounis: RCT on beta-1b, lopinavir–ritonavir, and ribavirin for patients with #covid19. More data, more confusion. #COVID19FOAM…
@rlamartini @ScottGottliebMD Thid is the study mentioned in the news. https://t.co/tnVRUpACnJ
Even Kaletra and ribavirin, almost ineffective drugs, work better if given early.
@csentropy Earlier the better. "Early treatment with a triple combination of modestly active antivirals is appropriate for the treatment of COVID-19 because the viral load of SARS-CoV-2 peaks at around the time of symptom onset." Unlike SARS/MERS. https://
RT @temblorita: Un tratamiento de dos semanas de terapia antiviral con interferón beta-1b más lopinavir-ritonavir y ribavirina, podría se e…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/P7eXpER3EB
RT @temblorita: Un tratamiento de dos semanas de terapia antiviral con interferón beta-1b más lopinavir-ritonavir y ribavirina, podría se e…
RCT on beta-1b, lopinavir–ritonavir, and ribavirin for patients with #covid19. More data, more confusion. #COVID19FOAM https://t.co/USm1w4Nyjq
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/NsPncRcOkR
RT @smoertelt: This was published the other day in the @TheLancet - interferon beta-1b, lopinavir–ritonavir, and ribavirin for COVID-19 pat…
RT @TallerVzlanoVIH: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @carpe_diem0820: 非重症COVID-19患者への早期カレトラ+リバビリン+IFβ1b vs カレトラ治療の研究 併用群でPCT陰性化が早く入院期間が短い Triple combination of interferon beta-1b, lopinavi…
RT @carpe_diem0820: 非重症COVID-19患者への早期カレトラ+リバビリン+IFβ1b vs カレトラ治療の研究 併用群でPCT陰性化が早く入院期間が短い Triple combination of interferon beta-1b, lopinavi…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and rib... https://t.co/nxVWGRXxec
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/23TO9GGGOa
@KTLA .@KTLA There are other options now. An antiviral drug cocktail shortens the amount of time #COVID19 patients test positive to 7 days (down from 12 days). https://t.co/h4yGOWO3xi
RT @nathanpsmad: Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et p…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
Vou ver,grato pela informação.
RT @jorroser: Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opcione…
@davecurtis314 @Siraris @UkNewalchemist1 @TheLancet Hospitals are a major ground for #COVID19 transmission, in particular for lethal 'high viral load' infections. I assume you mean the study below. Its saving grace is that "No patients died during the stud
RT @InternosPy: 🚨🆕 Triple combinación de interferón beta-1b, lopinavir-ritonavir y ribavirina en el tratamiento de pacientes ingresados e…
RT @EmilioAlegre1: ECA fase2 triple terapia (L/r+RBV+IFN-B sc) vs. L/r en 162 vs 81 pacientes PCR+ hospitalizados. Pero en Hong Kong, donde…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/9hXD3fKhyd
RT @nataliexdean: Earlier treatments. Antivirals are likely more effective when given early in the course of illness. So far we have been…
@JoFizonacero @TV_DanielS @danieljadue @TheLancet Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020; (publish
Les traitements de #DisCoVeRY plus que jamais d'actualité : seul essai académique qui teste le #remdesivir en #Europe et pourra confirmer/infirmer les données du #NIH + test de l'association lopi/rito + IFN 1 https://t.co/I5jI0D0SHE
RT @MsrMaker: Donc interferon, ribavirine et lopinavir/ritonavir pour des gens qui guérissent tout seuls, vraiment de mieux en mieux https:…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/nbE5xnLsHJ
Donc interferon, ribavirine et lopinavir/ritonavir pour des gens qui guérissent tout seuls, vraiment de mieux en mieux https://t.co/QIdtZN2UQO
@GPronaldo13 O mais promissor, saiu sábado agora: https://t.co/ISlRpPcZ2e
#Remdesivir no longer the only treatment option. Antiviral drug cocktail shortens the amount of time #COVID19 patients test positive to 7 days (down from 12 days). https://t.co/h4yGOWO3xi CC @EricTopol .@drsanjaygupta
RT @richardhorton1: Important early new data on combination treatment for mild-moderate COVID-19. Extremely encouraging.
@oatila @edyong209 Já viu este estudo? O que acha? https://t.co/vAANjuFp9I
@AntonioPBJunior https://t.co/Rwlzi8ybMo Ola Antônio. Esse estudo q acabou de sair é talvez o q d melhor exista sobre o covid, o primeiro controlado, multicentrico, randomizado usando coquetel de medicamentos. A cloroquina está indo p o lado do desuso por
@TV_DanielS @danieljadue @TheLancet Sí, lo q demuestran es q al cóctel de Lopinavir y Ritonavir cuando le acompañan interferon (triple combinación) el tratamiento es más efectivo y los pacientes se recuperan más rápidamente. Esto en un ensayo en Fase 2. ht
RT @emlitofnote: "The primary endpoint was time to achieve a negative RT-PCR result for SARS-CoV-2." ... why not a patient-oriented outcom…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @nathanpsmad: 🔥Interesting #RCT for #COVID19 #SARS_CoV_2 Interferon beta-1b, lopinavir–ritonavir, ribavirin in MILD patients (0 death,…